Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

Sanofi-Aventis

Sanofi-Aventis

  1. Mylan, Pfizer Settle Patent Lawsuit With Two Others
    Drugs.com logo Drugs.com 2 days ago

    EpiPen, used to treat severe allergic reactions, is manufactured for Canonsburg-based Mylan by a Pfizer subsidiary, Meridian Medical Technologies. The companies settled a patent infringement lawsuit with Intelliject and Sanofi-Aventis over...

  2. Pfizer, Mylan enter settlement agreement to resolve e-cue patent litigation
    News-Medical.net logo News-Medical.net 2 days ago

    According to the terms of the settlement, Intelliject and Sanofi-Aventis may launch e-cue no earlier than Nov. 15, 2012, subject to receipt of final approval from the U.S. Food and Drug Administration. Meridian manufactures EpiPen® Auto-Injector and...

  3. Getty Images logo Getty Images 9 months ago
    SACRAMENTO, CA - MAY 16: (L-R) James Driscoll of the USA and riding for Jamis-Sutter Home leads the breakaway group infront of Laszlo Bodrogi of France and riding for Team Type 1-Sanofi Aventis, Ben Jacques-Maynes of the USA and riding for Bissell Cycling...

    SACRAMENTO, CA - MAY 16: (L-R) James Driscoll of the USA and riding for Jamis-Sutter Home leads the breakaway group infront of Laszlo Bodrogi of France and riding for Team Type 1-Sanofi Aventis, Ben Jacques-Maynes of the USA and riding for Bissell Cycling... View Photo »

  4. This is one of those treatments that have been tossed around like a hot potato for the past decade or more ... For example, some rights to DiaPep277 were acquired by the company known as Aventis (which became Sanofi Aventis back in 1997), although full rights were reported to be acquired by the predeces...
    SOURCE: Diabetes Mine 1 month ago
  5. Hecla Mining Co. Fourth Quarter Earnings Sneak Peek
    Wall Street Cheat Sheet logo Wall Street Cheat Sheet 3 days ago

    GE is currently paying a dividend of 3.6% to shareholders. Pfizer (NYSE:PFE): Mylan and Pfizer announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis (NYSE:SNY)...

  6. Pfizer reaches settlement with EpiPen rival
    MLive.com logo MLive.com 3 days ago

    EpiPen is used to treat life-threatening allergic reactions, called anaphylaxis. The settlement agreement with Intelliject and Sanofi-Aventis will resolve pending patent litigation related to the new e-cue auto-injector, which will be manufactured and...

  7. Pfizer (PFE) Subsidiary Enters Epinephrine Auto-Injector Settlement (MYL) (SNY)
    Street Insider 3 days ago

    According to the terms of the settlement, Intelliject and Sanofi-Aventis may launch e-cue no earlier than Nov. 15, 2012, subject to receipt of final approval from the U.S. Food and Drug Administration. Meridian manufactures EpiPen Auto-Injector and...

  8. Getty Images logo Getty Images 9 months ago
    YUBA COUNTY, CA - MAY 16: (L-R) Timon Seubert of Germany and riding for Team Netapp, Laszlo Bodrogi of France and riding for Team Type 1-Sanofi Aventis, James Driscoll of the USA and riding for Jamis-Sutter Home and Ben Jacques-Maynes of the USA and riding...

    YUBA COUNTY, CA - MAY 16: (L-R) Timon Seubert of Germany and riding for Team Netapp, Laszlo Bodrogi of France and riding for Team Type 1-Sanofi Aventis, James Driscoll of the USA and riding for Jamis-Sutter Home and Ben Jacques-Maynes of the USA and riding... View Photo »

  9. Inexpensive but people like other companies. I like Bristol-Myers Squibb (BMY) and Sanofi-Aventis (SNY) for yield.
    SOURCE: The Street 2 months ago
  10. sanofi aventis, la qualité avant tout
    YouTube Logo YouTube Videos 11 months ago
  11. Salk researchers find new drug target for lung cancer
    EurekAlert logo EurekAlert 4 days ago

    The study was funded by the Ellison Medical Foundation, H.N. and Frances C. Berger Foundation, Ipsen/Biomeasure, Sanofi Aventis, Leducq Foundation, National Institutes of Health, Merieux Foundation, Prostate Cancer Foundation and the U.S. Department of...

  12. Berkshire Hathaway & Buffett’s Stock Holdings ‘L to Z’ (BRK-B, BRK-A, LMCA, MA, MTB, MCO, PG, SNY, TMK, USB, USG, UPS, VRSK, V, WMT, WPO, WFC)
    24x7 Wall St. logo 24x7 Wall St. 5 days ago

    AS last quarter and up from the quarter before that. Moody’s Corp. (NYSE: MCO) was 28.4 million; SAME AS last quarter but way down from prior quarters and years. Procter & Gamble (NYSE: PG) was 76.7 million shares, SAME AS last quarter but lower than...

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using Daylife platform, which helps you be more efficient and creative with content. It's designed for publishers, editors, and developers to build better content-based sites, services, and apps for clients and audiences. Learn More »

About Sanofi-Aventis

Wikipedia

Sanofi-Aventis (Euronext: SAN, NYSE: SNY), headquartered in Paris, France, is a multinational pharmaceutical company. The company is the world's fourth largest pharmaceutical company. Sanofi-Aventis engages in the research, development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but... Full Article

Related Photos

CEO of the pharmaceutical group Sanofi-Aventis Chris Viehbacher delivers a speech during a press conference to present the 2010 annual financial results of the company, on February 09, 2011 in Paris.
Pause Play 1/11
prev
  1. CEO of the pharmaceutical group Sanofi-Aventis Chris Viehbacher delivers a speech during a press conference to present the 2010 annual financial results of the company, on February 09, 2011 in Paris. Getty Images logo Getty Images 11 months ago

    CEO of the pharmaceutical group Sanofi-Aventis Chris Viehbacher delivers a speech during a press conference to present the 2010 annual financial results of the company, on February 09, 2011 in Paris.

    View Photo »
  2. Gerard Le Fur, Chief Executive Officer of Sanofi-Aventis pharmaceutical group attends a press conference announcing the 2007 financial results of the French company, on February 12, 2008 in Paris. Getty Images logo Getty Images 11 months ago

    Gerard Le Fur, Chief Executive Officer of Sanofi-Aventis pharmaceutical group attends a press conference announcing the 2007 financial results of the French company, on February 12, 2008 in Paris.

    View Photo »
  3. Senior Executive Vice President of Sanofi Aventis, Gerard Le Fur, holds a press conference, 13 February 2007 in Paris, to present the 2006 results of the French pharmaceutical group. Getty Images logo Getty Images 11 months ago

    Senior Executive Vice President of Sanofi Aventis, Gerard Le Fur, holds a press conference, 13 February 2007 in Paris, to present the 2006 results of the French pharmaceutical group.

    View Photo »
  4. Pharmaceutical group Sanofi-Aventis' Chief Executive Jean-Francois Dehecq smiles addresses the group's general meeting in Paris 31 May 2006. Sanofi-Aventis chief executive Jean-Francois Dehecq said he will propose to nominate Senior Executive Vice President Gerard Le Fur to take over... Getty Images logo Getty Images 11 months ago

    Pharmaceutical group Sanofi-Aventis' Chief Executive Jean-Francois Dehecq smiles addresses the group's general meeting in Paris 31 May 2006. Sanofi-Aventis chief executive Jean-Francois Dehecq said he will propose to nominate Senior Executive Vice President Gerard Le Fur to take over...

    View Photo »
  5. Pharmaceutical French group Sanofi-Aventis chairman Jean-Francois Dehecq holds a press conference 24 February 2006 in Paris to present the full-year 2005 results. Sanofi-Aventis announced a series of positive drug research developments. Getty Images logo Getty Images 11 months ago

    Pharmaceutical French group Sanofi-Aventis chairman Jean-Francois Dehecq holds a press conference 24 February 2006 in Paris to present the full-year 2005 results. Sanofi-Aventis announced a series of positive drug research developments.

    View Photo »
  6. Pharmaceutical French group Sanofi-Aventis Gerard Le Fur, Executive Vice President for Scientific and Medical Operations, holds a press conference with Chairman Jean-Francois Dehecq (unseen) 24 February 2006 in Paris to present the full-year 2005 results. Sanofi-Aventis announced a... Getty Images logo Getty Images 11 months ago

    Pharmaceutical French group Sanofi-Aventis Gerard Le Fur, Executive Vice President for Scientific and Medical Operations, holds a press conference with Chairman Jean-Francois Dehecq (unseen) 24 February 2006 in Paris to present the full-year 2005 results. Sanofi-Aventis announced a...

    View Photo »
  7. SACRAMENTO, CA - MAY 16: (L-R) James Driscoll of the USA and riding for Jamis-Sutter Home leads the breakaway group infront of Laszlo Bodrogi of France and riding for Team Type 1-Sanofi Aventis, Ben Jacques-Maynes of the USA and riding for Bissell Cycling and Timon Seubert of Germany and... Getty Images logo Getty Images 9 months ago

    SACRAMENTO, CA - MAY 16: (L-R) James Driscoll of the USA and riding for Jamis-Sutter Home leads the breakaway group infront of Laszlo Bodrogi of France and riding for Team Type 1-Sanofi Aventis, Ben Jacques-Maynes of the USA and riding for Bissell Cycling and Timon Seubert of Germany and...

    View Photo »
  8. YUBA COUNTY, CA - MAY 16: (L-R) Timon Seubert of Germany and riding for Team Netapp, Laszlo Bodrogi of France and riding for Team Type 1-Sanofi Aventis, James Driscoll of the USA and riding for Jamis-Sutter Home and Ben Jacques-Maynes of the USA and riding for Bissell Cycling work together... Getty Images logo Getty Images 9 months ago

    YUBA COUNTY, CA - MAY 16: (L-R) Timon Seubert of Germany and riding for Team Netapp, Laszlo Bodrogi of France and riding for Team Type 1-Sanofi Aventis, James Driscoll of the USA and riding for Jamis-Sutter Home and Ben Jacques-Maynes of the USA and riding for Bissell Cycling work together...

    View Photo »
  9. France's Industry Minister Eric Besson (C) flanked by the president of French pharmaceutical giant Sanofi-Aventis in France, Christian Lajoux (L) and Lyon mayor, Gerard Collomb (R), visits the new vaccine manufacturing plant of the Pasteur Sanofi group on May 13, 2011, in Neuville-sur-Saône,... Getty Images logo Getty Images 9 months ago

    France's Industry Minister Eric Besson (C) flanked by the president of French pharmaceutical giant Sanofi-Aventis in France, Christian Lajoux (L) and Lyon mayor, Gerard Collomb (R), visits the new vaccine manufacturing plant of the Pasteur Sanofi group on May 13, 2011, in Neuville-sur-Saône,...

    View Photo »
  10. A picture taken on February 1, 2011 shows a vaccine assembly line in the vaccine production factory of Sanofi-Pasteur, the vaccine branch of the French pharmaceutical giant Sanofi-Aventis, in Marcy-l'Etoile, outside Lyon. Sanofi-Aventis won control of giant US biotechnology group... Getty Images logo Getty Images 11 months ago

    A picture taken on February 1, 2011 shows a vaccine assembly line in the vaccine production factory of Sanofi-Pasteur, the vaccine branch of the French pharmaceutical giant Sanofi-Aventis, in Marcy-l'Etoile, outside Lyon. Sanofi-Aventis won control of giant US biotechnology group...

    View Photo »
  11. A picture taken on February 16, 2011 in Saint-Germain-en-Laye, west of Paris shows the facade of the US biotechnology group Genzyme's French headquarters. French pharmaceutical giant Sanofi-Aventis won control of Genzyme after increasing its offer considerably in a drawn out battle. Getty Images logo Getty Images 11 months ago

    A picture taken on February 16, 2011 in Saint-Germain-en-Laye, west of Paris shows the facade of the US biotechnology group Genzyme's French headquarters. French pharmaceutical giant Sanofi-Aventis won control of Genzyme after increasing its offer considerably in a drawn out battle.

    View Photo »
next
Getty Images logo Getty Images 11 months ago

CEO of the pharmaceutical group Sanofi-Aventis Chris Viehbacher delivers a speech during a press conference to present the 2010 annual financial results of the company, on February 09, 2011 in Paris.

View Photo »
View All »

Related Topics

  1. Bristol-Myers Squibb Bristol-Myers Squibb
  2. Abbott Laboratories Abbott Laboratories
  3. Genzyme Corporation Genzyme Corporation
  4. NASDAQ NASDAQ
  5. Medtronic, Inc. Medtronic, Inc.
  6. GlaxoSmithKline Inc GlaxoSmithKline Inc

Timeline of Coverage

  1. Click to see all coverage from Jan 03, 2012
    2
    January 03, 2012
  2. Click to see all coverage from Jan 04, 2012
    0
    January 04, 2012
  3. Click to see all coverage from Jan 05, 2012
    2
    January 05, 2012
  4. Click to see all coverage from Jan 06, 2012
    0
    January 06, 2012
  5. Click to see all coverage from Jan 07, 2012
    0
    January 07, 2012
  6. Click to see all coverage from Jan 08, 2012
    1
    January 08, 2012
  7. Click to see all coverage from Jan 09, 2012
    0
    January 09, 2012
  8. Click to see all coverage from Jan 10, 2012
    0
    January 10, 2012
  9. Click to see all coverage from Jan 11, 2012
    3
    January 11, 2012
  10. Click to see all coverage from Jan 12, 2012
    1
    January 12, 2012
  11. Click to see all coverage from Jan 13, 2012
    0
    January 13, 2012
  12. Click to see all coverage from Jan 14, 2012
    0
    January 14, 2012
  13. Click to see all coverage from Jan 15, 2012
    0
    January 15, 2012
  14. Click to see all coverage from Jan 16, 2012
    0
    January 16, 2012
  15. Click to see all coverage from Jan 17, 2012
    6
    January 17, 2012
  16. Click to see all coverage from Jan 18, 2012
    4
    January 18, 2012
  17. Click to see all coverage from Jan 19, 2012
    0
    January 19, 2012
  18. Click to see all coverage from Jan 20, 2012
    0
    January 20, 2012
  19. Click to see all coverage from Jan 21, 2012
    0
    January 21, 2012
  20. Click to see all coverage from Jan 22, 2012
    0
    January 22, 2012
  21. Click to see all coverage from Jan 23, 2012
    0
    January 23, 2012
  22. Click to see all coverage from Jan 24, 2012
    0
    January 24, 2012
  23. Click to see all coverage from Jan 25, 2012
    0
    January 25, 2012
  24. Click to see all coverage from Jan 26, 2012
    2
    January 26, 2012
  25. Click to see all coverage from Jan 27, 2012
    0
    January 27, 2012
  26. Click to see all coverage from Jan 28, 2012
    0
    January 28, 2012
  27. Click to see all coverage from Jan 29, 2012
    0
    January 29, 2012
  28. Click to see all coverage from Jan 30, 2012
    0
    January 30, 2012
  29. Click to see all coverage from Jan 31, 2012
    1
    January 31, 2012
  30. Click to see all coverage from Feb 01, 2012
    1
    February 01, 2012
  31. Click to see all coverage from Feb 02, 2012
    0
    February 02, 2012
  32. Click to see all coverage from Feb 03, 2012
    1
    February 03, 2012
  33. Click to see all coverage from Feb 04, 2012
    0
    February 04, 2012
  34. Click to see all coverage from Feb 05, 2012
    0
    February 05, 2012
  35. Click to see all coverage from Feb 06, 2012
    0
    February 06, 2012
  36. Click to see all coverage from Feb 07, 2012
    2
    February 07, 2012
  37. Click to see all coverage from Feb 08, 2012
    4
    February 08, 2012
  38. Click to see all coverage from Feb 09, 2012
    1
    February 09, 2012
  39. Click to see all coverage from Feb 10, 2012
    2
    February 10, 2012
  40. Click to see all coverage from Feb 11, 2012
    0
    February 11, 2012
  41. Click to see all coverage from Feb 12, 2012
    0
    February 12, 2012
  42. Click to see all coverage from Feb 13, 2012
    1
    February 13, 2012
  43. Click to see all coverage from Feb 14, 2012
    0
    February 14, 2012
  44. Click to see all coverage from Feb 15, 2012
    0
    February 15, 2012
  45. Click to see all coverage from Feb 16, 2012
    1
    February 16, 2012
  46. Click to see all coverage from Feb 17, 2012
    0
    February 17, 2012
  47. Click to see all coverage from Feb 18, 2012
    0
    February 18, 2012
  48. Click to see all coverage from Feb 19, 2012
    0
    February 19, 2012

Related Videos

  1. Videosurf
    1. Capstone's Shah Discusses Sanofi-Aventis Bid for Genzyme : Video
      Capstone's Shah Discusses Sanofi-Aventis Bid fo...
    2. Managing Nasal Allergies - Video
      Managing Nasal Allergies - Video
    3. SQUAWK BOX EUROPE : Sanofi-Aventis CEO on Genzyme Bid
      SQUAWK BOX EUROPE : Sanofi-Aventis CEO on Genzy...
      12 months ago
    4. power lunch : Sanofi-Aventis Q1 Profits Up
      power lunch : Sanofi-Aventis Q1 Profits Up
      22 months ago
    5. Sanofi-Aventis : A Good Buy?
      Sanofi-Aventis : A Good Buy?
      15 months ago
    6. Sanofi-Aventis CEO on Strategy
      Sanofi-Aventis CEO on Strategy
      36 months ago
    View All Videosurf Videos »

Related Quotes

  • Previous
  • Next
  • 1/5
  1. This is one of those treatments that have been tossed around like a hot potato for the past decade or more ... For example, some rights to DiaPep277 were acquired by the company known as Aventis (which became Sanofi Aventis back in 1997), although full rights were reported to be acquired by the predeces...
    SOURCE: Diabetes Mine 1 month ago
  2. Inexpensive but people like other companies. I like Bristol-Myers Squibb (BMY) and Sanofi-Aventis (SNY) for yield.
    SOURCE: The Street 2 months ago
  3. one of the slower growers and I don't want to be there. I prefer Celgene (NASDAQ: CELG) or Sanofi-Aventis (NYSE: SNY).
    SOURCE: Benzinga.com 2 months ago
  4. That's one of the slower growers and I don't want to be there. I prefer Celgene (CELG) or Sanofi-Aventis (SNY).
    SOURCE: The Street 2 months ago
  5. It's OK. I prefer Sanofi-Aventis (SNY) or Abbott Laboratories (ABT) or Bristol-Myers Squibb (BMY).
    SOURCE: The Street 2 months ago
View All »